Lifirafenib Uses, Dosage, Side Effects and more
Lifirafenib is under investigation in clinical trial NCT03641586 (The Study of BGB-283 in Chinese Subjects With Local Advanced or Metastatic Malignant Solid Tumor).
| Attribute | Details |
|---|---|
| Trade Name | Lifirafenib |
| Generic | Lifirafenib |
| Lifirafenib Other Names | Lifirafenib |
| Type | |
| Formula | C25H17F3N4O3 |
| Weight | Average: 478.431 Monoisotopic: 478.125274912 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
